Evidence map›Paper›PMID 25308446›Full record

ArticleMetabolism: clinical and experimental2014

The Murphy Roths Large (MRL) mouse strain is naturally resistant to high fat diet-induced hyperglycemia.

Aaron J Mull, Tirsit K Berhanu, Nathan W Roberts, Ahlke Heydemann

Abstract read
In one paragraph

Article in Metabolism: clinical and experimental, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Aaron J Mull *Department of Physiology and Biophysics, The University of Illinois at Chicago, Chicago, IL 60612, USA.
Tirsit K Berhanu *Department of Physiology and Biophysics, The University of Illinois at Chicago, Chicago, IL 60612, USA.
Nathan W RobertsDepartment of Physiology and Biophysics, The University of Illinois at Chicago, Chicago, IL 60612, USA.
Ahlke HeydemannDepartment of Physiology and Biophysics, The University of Illinois at Chicago, Chicago, IL 60612, USA.

Funding

Mechanisms and therapies for respiratory muscle failureR01HL102322 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI HEYDEMANN, AHLKE · 2011 to 2014
$1.5M
NHLBI NIH HHS R01 HL102322PHS HHS R01 RHL102322A
6 · The paper itself

Abstract

objectiveDue to their previously identified naturally and chronically increased levels of skeletal muscle pAMPK we hypothesized and now investigated whether the MRL/MpJ (MRL) mice would be resistant to high fat diet (HFD)-induced metabolic changes. MATERIALS/

methodsThree-week old male MRL and control C57Bl/6 (B6) mice were randomly assigned to 12weeks of high fat diets (HFD) or control diets (CD). Weekly animal masses and fasting blood glucose measurements were acquired. During the last week of diet intervention, fasted animals were subjected to glucose and insulin tolerance tests. At harvest, tissues were dissected for immunoblots and serum was collected for ELISA assays.

resultsThe MRL mouse strain is known for its ability to regenerate ear punch wounds, cardiac cryoinjury, and skeletal muscle disease. Despite gaining weight and increasing their fat deposits the MRL mice were resistant to all other indicators of HFD-induced metabolic alterations assayed. Only the HFD-B6 mice displayed fasting hyperglycemia, hyperinsulinemia and hypersensitivity to glucose challenge. HFD-MRL mice were indistinguishable from their CD-MRL counterparts in these metrics. Skeletal muscles from the HFD-MRL contained heightened levels of pAMPK, even above their CD counterparts.

conclusionsThe MRL mouse strain is the first naturally occurring mouse strain that we are aware of that is resistant to HFD-induced metabolic changes. Furthermore, the increased pAMPK suggests a proximal mechanism for these beneficial metabolic differences. We further hypothesize that these metabolic differences and plasticity provide the basis for the MRL mouse strain's super healing characteristics. This project's ultimate aim is to identify novel therapeutic targets, which specifically increase pAMPK.

Indexed as

AMP-Activated Protein KinasesAnimalsBiomarkersBlood GlucoseDiabetes Mellitus, Type 2Diet, High-FatEnzyme-Linked Immunosorbent AssayGlucose IntoleranceGlucose Transporter Type 4HyperglycemiaHyperinsulinismInsulinLipidsMaleMiceMice, Inbred C57BLAMP-Activated Protein KinasesBiomarkersBlood GlucoseGlucose Transporter Type 4InsulinLipidsSlc2a4 protein, mouseAMPKAnimal modelGenetic resistanceHigh fat dietSkeletal muscle metabolism

Identifiers

PMID25308446
PMCPMC4252560

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.